Literature DB >> 10523860

Human mammary epithelial cells exhibit a differential p53-mediated response following exposure to ionizing radiation or UV light.

K M Meyer1, S M Hess, T D Tlsty, S A Leadon.   

Abstract

The tumor suppressor protein, p53, plays a critical role as a transcriptional activator of downstream target genes involved in the cellular response to DNA damaging agents. We examined the cell cycle checkpoint response of human mammary epithelial cells (HMEC) and their isogenic fibroblast counterparts to ionizing (IR) and ultraviolet (UV) radiation, two genotoxic agents whose DNA damage response pathways involve p53. Using flow cytometric analysis, we found that both mortal and immortalized HMEC, which contain wild-type p53 sequence, do not exhibit a G1 arrest in response to IR, but show an intact G2 checkpoint. Supportive evidence from Western analyses revealed that there was neither an increase in p53 nor one of its downstream targets, p21WAF1, in HMEC exposed to IR. In contrast, isogenic mammary fibroblasts arrest at the G1 checkpoint and induce the p53 and p21WAF1 proteins following IR. By comparison, HMEC exposed to UV displayed an S phase arrest and induced the expression of p53 and p21WAF1. Our results show that the cellular response to DNA damage depends on both the type of damage introduced into the DNA and the specific cell type.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1999        PMID: 10523860     DOI: 10.1038/sj.onc.1202977

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

Review 1.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

2.  Replication of an E1B 55-kilodalton protein-deficient adenovirus (ONYX-015) is restored by gain-of-function rather than loss-of-function p53 mutants.

Authors:  Byron Hann; Allan Balmain
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

3.  FISH-based analysis of 10- and 25-kV soft X-ray-induced DNA damage in 184A1 human mammary epithelial cells.

Authors:  E Beyreuther; W Dörr; A Lehnert; E Lessmann; J Pawelke
Journal:  Radiat Environ Biophys       Date:  2011-12-24       Impact factor: 1.925

4.  Gene expression pattern of insect fat body cells from in vitro challenge to cell line establishment.

Authors:  Huan Zhang; Qian Meng; Ping Tang; Xuan Li; Wei Zhu; Guiling Zhou; Ruihao Shu; Jihong Zhang; Qilian Qin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-09-12       Impact factor: 2.416

5.  The p53/p21 DNA damage-signaling pathway is defective in most meningioma cells.

Authors:  Huda H Al-Khalaf; Boleslaw Lach; Ayman Allam; Ahmed AlKhani; Salman A Alrokayan; Abdelilah Aboussekhra
Journal:  J Neurooncol       Date:  2007-01-24       Impact factor: 4.130

Review 6.  Loss of chromosomal integrity in human mammary epithelial cells subsequent to escape from senescence.

Authors:  T D Tlsty; S R Romanov; B K Kozakiewicz; C R Holst; L M Haupt; Y G Crawford
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

7.  Overexpression of c-Myc alters G(1)/S arrest following ionizing radiation.

Authors:  Joon-Ho Sheen; Robert B Dickson
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

Review 8.  Maintenance of genomic integrity after DNA double strand breaks in the human prostate and seminal vesicle epithelium: the best and the worst.

Authors:  Sari Jäämaa; Marikki Laiho
Journal:  Mol Oncol       Date:  2012-06-18       Impact factor: 6.603

Review 9.  Contribution of p53 to metastasis.

Authors:  Emily Powell; David Piwnica-Worms; Helen Piwnica-Worms
Journal:  Cancer Discov       Date:  2014-03-21       Impact factor: 39.397

10.  Dissecting cellular responses to irradiation via targeted disruptions of the ATM-CHK1-PP2A circuit.

Authors:  Stela S Palii; Yuxia Cui; Cynthia L Innes; Richard S Paules
Journal:  Cell Cycle       Date:  2013-03-05       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.